Dicerna Pharma (DRNA) Reports In-Line Q4 EPS
Dicerna Pharma (NASDAQ: DRNA) reported Q4 EPS of ($0.57), in-line with the analyst estimate of ($0.57).
For earnings history and earnings-related data on Dicerna Pharma (DRNA) click here.
Dicerna Pharma (NASDAQ: DRNA) reported Q4 EPS of ($0.57), in-line with the analyst estimate of ($0.57).
For earnings history and earnings-related data on Dicerna Pharma (DRNA) click here.